Prostate Cancer: Page 2
Veracyte announces data for prostate genomic classifier
September 21, 2022
Veracyte announces data at ESMO 2022 for prostate genomic classifier
September 11, 2022
Veracyte to present abstracts at ESMO Congress 2022
August 30, 2022
Nanostics secures CE Mark for ClarityDx Prostate
August 22, 2022
Genetic risk score may reduce invasive prostate biopsies
August 18, 2022